Literature DB >> 25615257

Pure laparoscopic augmentation ileocystoplasty.

Rafael B Rebouças1, Rodrigo C Monteiro1, Thiago N S de Souza1, Augusto J de Aragão1, Camila R T Burity1, Júlio C de A Nóbrega1, Natália S C de Oliveira1, Ramon B Abrantes1, Luiz B Dantas Júnior1, Ricardo Cartaxo Filho1, Gustavo R P Negromonte1, Rafael da C R Sampaio1, Cesar A Britto1.   

Abstract

INTRODUCTION: Guillain-Barre syndrome is an acute neuropathy that rarely compromises bladder function. Conservative management including clean intermittent catheterization and pharmacotherapy is the primary approach for hypocompliant contracted bladder. Surgical treatment may be used in refractory cases to improve bladder compliance and capacity in order to protect the upper urinary tract. We describe a case of pure laparoscopic augmentation ileocystoplasty in a patient affected by Guillain-Barre syndrome.
PRESENTATION: A 15-year-old female, complaining of voiding dysfunction, recurrent urinary tract infection and worsening renal function for three months. A previous history of Guillain-Barre syndrome on childhood was related. A voiding cystourethrography showed a pine-cone bladder with moderate post-void residual urine. The urodynamic demonstrated a hypocompliant bladder and small bladder capacity (190 mL) with high detrusor pressure (54 cmH2O). Nonsurgical treatments were attempted, however unsuccessfully.

Entities:  

Mesh:

Year:  2014        PMID: 25615257     DOI: 10.1590/S1677-5538.IBJU.2014.06.20

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  2 in total

1.  Editor's Comment - Best videos of the year for the International Brazilian Journal of Urology 2014.

Authors:  Philippe E Spiess
Journal:  Int Braz J Urol       Date:  2015 May-Jun       Impact factor: 1.541

2.  Robot-assisted laparoscopic augmentation ileocystoplasty and excision of an intraperitoneal mass: a case report.

Authors:  Hao Su; Shuiqing Wu; Yinhuai Wang; Shiqi Peng
Journal:  J Int Med Res       Date:  2019-06-10       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.